TIGERMED: JPMorgan Chase & Co. Acquires Shares, Long Position Rises to 20.63%
HK Disclosure
Yesterday
On September 21, 2026, JPMorgan Chase & Co. recalled 1.03 million borrowed H shares of TIGERMED (03347) under a securities lending agreement. This transaction, which is not a direct on-market dealing, resulted in a long position of approximately 25.40 million shares.
Prior to the recall of borrowed shares, JPMorgan Chase & Co.'s long position in TIGERMED was 25.40 million shares, representing 20.62%; following the recall, the holding changed to 25.40 million shares, with the long position ratio rising to 20.63%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.